Side-by-side comparison of AI visibility scores, market position, and capabilities
Maze is a continuous product discovery platform for unmoderated usability tests — importing Figma prototypes and measuring click paths, misclick rates, and task completion from real users.
Maze is a continuous product discovery platform that enables product teams to run unmoderated user research without the scheduling overhead of live moderated sessions. Teams can import prototypes directly from Figma, Marvel, or InVision and launch usability tests to real participants within minutes. The platform captures click paths, misclick rates, task completion times, and qualitative responses, then synthesizes results into quantitative metrics that non-researchers can interpret and act on. This self-serve research model compresses the feedback loop between design decisions and validated user data from weeks to days.
SF webhooks-as-a-service platform delivering billions of webhooks with reliability guarantees for Fortune 500 to startups; YC W21 $13M a16z Series A competing with Hookdeck for developer webhook infrastructure.
Svix is a San Francisco-based webhooks infrastructure platform — backed by Y Combinator (W21) with $13 million raised including a $10.4 million Series A in February 2023 led by Andreessen Horowitz with Y Combinator, Aleph, and angels including founders and CTOs of GitHub, PagerDuty, Segment, and Lookout — providing SaaS companies and API-driven products with enterprise-ready webhook delivery infrastructure (both open-source self-hosted and cloud-managed) that handles the reliability, scalability, security, and developer experience requirements of sending billions of webhooks to customers, eliminating the webhook infrastructure engineering that currently requires 2-4 months of developer time to build correctly. Founded in 2021 and serving Fortune 500 enterprises to startups, Svix enables companies to ship webhook functionality to customers in days rather than months.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.